监测口蹄疫抗体的液相阻断ELISA法的改进和体会

液相阻断ELISA（LBE）法由于具有高度的敏感性、特异性和重复性,目前被广泛应用于动物免疫抗体效果监测实践工作中,特别是为防控牛、羊亚洲I型口蹄疫（FMD）做出了积极的贡献。但该方法操作繁琐,稍有不慎就会导致实验结果发生偏差或试验失败,笔者就该方法应用于亚I型口蹄疫抗体检测中的改进和体会作一总结。     

新城疫活疫苗对控制鸡大肠杆菌病的效果观察

为了研究鸡新城疫活疫苗紧急免疫控制鸡大肠杆菌病的效果,通过大肠杆菌人工感染30日龄蛋鸡,待出现病症后,紧急免疫新城疫La-sota弱毒苗(Ⅳ系)4羽份.免疫后5～17 d,通过血凝抑制试验测定血清新城疫抗体水平,试验组新城疫抗体水平逐步提高,对照组抗体略有下降,免疫后17 d两组抗体水平差异显著(P＜0.05);对照组...     

不同采毛方式对长毛兔血清蛋白及含氮代谢物水平的影响

文章分析了3种方式（剪毛、直接拔毛和药物拔毛）对皖系长毛兔采毛前、采毛后0、4、8、24、48 h血清蛋白及含氮代谢物变化规律的影响.结果发现：3种采毛方式均显著上调血清总蛋白和肌酐水平,而血清白蛋白仅受药物拔毛影响而显著上调;药物拔毛显著上调血清总胆红素和直接胆红素水平,同时直接胆红素还受其他两种采毛方式影响而显著下调;两种拔毛方式（直接拔毛和药物拔毛）显著上调血清尿素和尿酸水平,但剪毛对这两个指标没有影响.长毛兔在采毛后48 h内,多数血清指标可恢复到采毛前水平,或呈恢复趋势;该研究筛选获得采毛应激指标血清总蛋白和肌酐,拔毛应激指标尿素和尿酸,同时发现肌酐、白蛋白和胆红素受地塞米松的显著影响.该研究结果可为初步揭示不同采毛方式应激生化机制提供参考.     

蛋鸭场鸭坦布苏病毒病的流行、诊断与防控

鸭坦布苏病毒病是严重危害养鸭业的传染病,给养鸭户特别是蛋鸭养殖户造成了巨大经济损失。本文结合江西省近年来的流行病学调查和国内外学者研究资料,对鸭坦布苏病毒病的主要流行病学特征、江西省蛋鸭场流行概况以及诊断方法与防控措施等进行了综述,以期为该病防控提供参考。     

新时期蚕业技术推广方式研究

在传统蚕业向现代蚕业转变的新时期,要提高土地产出率、劳动生产率、资源利用率,必须创新蚕桑技术推广方式,根据不同群体的个性化需求提供针对性的技术服务,采取印发实用技术资料、应用多媒体培训手段、设立专家咨询电话、建立蚕业短信平台、进行现场示范培训、培育示范大户、建立蚕需物资配送网络、创立蚕业生产数据库等群众看得见、摸得着、直观、简便的推广方式,及时、有效地将实用技术传递到蚕农手中。     

夏季日粮中主要营养水平对肉种母鸡生产性能的影响

为研究夏季日粮中粗脂肪、粗蛋白、赖氨酸和蛋氨酸水平对肉种鸡生产性能的影响,27周龄良凤肉用种母鸡随机分为4个处理,每个处理3个重复,每个重复为490只,处理一饲喂对照日粮(CF2.7%,CP16.5%,Lys0.83%,Met0.40%),处理二饲喂高脂肪日粮(CF5.43%),处理三饲喂高蛋白日粮(CP18.2%),处理四饲喂高赖氨酸和蛋氨酸日粮(Lys0.91%,Met0.44%),试验期共112天。结果表明,对照日粮的营养水平是适合的,在此基础上分别增加日粮的粗脂肪水平、粗蛋白水平、蛋氨酸和赖氨酸水平,都不能提高肉种母鸡的生产性能,也不能减轻夏季炎热带来的影响。     

Recombinant pseudorabies virus expressing P12A and 3C of FMDV can partially protect piglets against FMDV challenge

One of the crucial factors for evaluation of an effective genetically engineered vaccine is whether susceptible animals are protected from virus challenge after vaccination. In this study, a recombinant pseudorabies virus (PRV-P12A3C) that expressed capsid precursor polypeptide P12A and nonstructural protein 3C of foot-and-mouth disease virus (FMDV) was used as a vaccine. The expression of P12A3C and its immunogenicity and protective efficacy against FMDV challenge were measured. Humoral and cellular immune responses were evaluated after each immunization. Subsequently, each piglet was challenged with 1000 ID₅₀ (50% infection dose) FMDV serotype O, named OR/80, which is used to produce vaccine in China. PRV-P12A3C induced a high level of neutralizing antibody and FMDV-specific lymphocytes. Inactivated vaccine provided 100% protection, and the vector strain (TK⁻/gE⁻/gI⁻) showed no protection. PRV-P12A3C induced 60% protection, compared with piglets that were vaccinated with TK⁻/gE⁻/gI⁻. The severity of clinical signs for the remaining two piglets was lighter and the appearance of vesicles was delayed.     

犬Ⅱ型腺病毒自然弱毒株的分离与鉴定

从一只３月龄病犬中分离出一株犬腺病毒（ＣＡＶ）,暂定名为ＹＣＡ１８。从一系列形态学、生理化学、生物学和分子病毒学实验证明这是一株Ⅱ型犬腺病毒自然弱毒。此毒株能在犬、猪肾原代细胞和传代细胞系上生长,能产生腺病毒感染的特征性细胞病变,细胞肿胀,变圆和呈“葡萄串样”。在细胞核内可见病毒粒子及其前本的晶格状排列,病毒粒子呈２０面体立体对称,表面有排列整齐的壳粒;能抵抗乙醚的处理,在ＰＨ３及５０℃温度中稳定     

家蚕病原性微孢子虫孢子表面蛋白的选择性分离与总蛋白比较分析

选择性分离了Ｎｏｓｅｍａｂｏｍｂｙｃｉｓ孢子表面蛋白和总蛋白，采用ＳＤＳ－ＰＡＧＥ检测发现，孢子表面蛋白由分子量不同的３种亚基（３２０００、２６０００、２４５００Ｄａ）组成，其总蛋白至少包括２５个条带。同时将从养蚕生产中收集到的两种微粒子ＭＡ－１和ＭＤ－１以及从野外昆虫收集到的微孢子虫Ｐｈａ－Ｍ和Ｈａ－Ｍ与Ｎ．ｂｏｍｂｙｃｉｓ进行了比较，发现不同微孢子虫间蛋白组成有差异。     

The 16MΔvjbR as an ideal live attenuated vaccine candidate for differentiation between Brucella vaccination and infection

Brucellosis brings great economic burdens for developing countries. Live attenuated vaccines are the most efficient means for prevention and control of animal Brucellosis. However, the difficulties of differentiating of infection from vaccine immunization, which is essential for eradication programs, limit their applications. Therefore, the development of a vaccine that could differentiate infection from immunization will overcome the limitations and get extensive application. VjbR is a quorum sensing regulator involving in Brucella's intracellular survival. The vjbR∷Tn5 mutants have been proven effective against wild type strain challenge, implying its possibility of use in vaccine candidate development. To further evaluate this candidate gene, in the present study, the antigenicity of purified recombinant VjbR protein was analyzed. Antibodies to Brucella melitensis VjbR could be detected in sera from patients and animals with brucellosis but not in control ones, implying the potential use of this protein as a diagnostic antigen. Then a vjbR mutant of B. melitensis 16M was constructed by replacing the vjbR with kanamycin gene. The mutant showed reduced survival in macrophage and mice. Vaccination of BALB/c mice with 16MΔvjbR conferred significant protective immunity against B. melitensis strain 16M challenges, being equivalent to which induced by the license vaccine Rev.1. The vjbR deletion mutant elicited an anti-Brucella-specific immunoglobulin G response and induced the secretion of gamma interferon and interleukin-10. The most importance is that, the use of vjbR mutants as vaccines in association with diagnostic tests based on the VjbR antigen would allow the serological differentiation between infected and vaccinated animals. These results suggest that 16MΔvjbR is an ideal live attenuated vaccine candidate against B. melitensis and deserves further evaluation for vaccine development.